Burning Rock Biotech: Q1 Earnings Insights

Burning Rock Biotech BNR reported its Q1 earnings results on Tuesday, May 31, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Burning Rock Biotech missed estimated earnings by 8.33%, reporting an EPS of $-0.39 versus an estimate of $-0.36.

Revenue was up $5.11 million from the same period last year.

Last quarter the company missed on EPS by $0.11 which was followed by a 5.32% increase in the share price the next day.

Here's a look at Burning Rock Biotech's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.27	-0.25	-0.15	-0.23
EPS Actual	-0.38	-0.25	-0.30	-0.25
Revenue Estimate	21.47M	20.15M	21.41M	19.56M
Revenue Actual	23.12M	19.65M	19.71M	16.27M

To track all earnings releases for Burning Rock Biotech visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.